Characterization of Vixotrigine, a Broad-Spectrum Voltage-Gated Sodium Channel Blocker

Area of Science:

• Neuroscience
• Pharmacology
• Ion Channel Biology

Background:

• Voltage-gated sodium channels (Navs) are critical for neuronal excitability and are key targets for treating epilepsy and neuropathic pain.
• While subtype-specific Nav blockers offer potential for targeted therapies, broadly acting inhibitors have demonstrated clinical efficacy.

Purpose of the Study:

• To systematically characterize the novel Nav blocker, vixotrigine.
• To determine the potency, state-dependence, and spectrum of action of vixotrigine on Nav subtypes.

Main Methods:

• Recombinant expression systems were used to study Nav subtype inhibition.
• Electrophysiological techniques, including voltage-clamp recordings, were employed.
• Native sodium channels in rodent dorsal root ganglion neurons were analyzed.

Main Results:

• Vixotrigine exhibits voltage- and use-dependent inhibition of Navs, indicative of state-dependent block.
• It potently inhibits both peripheral and central Nav subtypes (use-dependent IC50: 1.76–5.12 μM).
• Vixotrigine shows broader action than Nav1.7/1.8-specific blockers and shifts inactivation curves in native channels.

Conclusions:

• Vixotrigine is a broad-spectrum, state-dependent Nav blocker.
• Its neurophysiological profile suggests potential therapeutic applications in neurological disorders.
• The compound rapidly inhibits Navs and prolongs recovery from inactivation.